Efficacy of Miltefosine for the Treatment of American Cutaneous Leishmaniasis

ABSTRACT: Miltefosine is an oral agent used for cutaneous leishmaniasis treatment. An open-label, randomized, phase III clinical trial was carried out in the Colombian army population. Miltefosine, 50 mg capsule was taken orally three times per day for 28 days (N = 145) or meglumine antimoniate, 20...

Full description

Autores:

Vélez Bernal, Iván Darío
López Carvajal, Liliana
Sánchez, Ximena
Mestra Palomino, Laureano Alberto
Rojas Arbeláez, Carlos Alberto
Rodríguez, Erwin

Tipo de recurso:

Article of investigation

Fecha de publicación:

2010

Institución:

Universidad de Antioquia

Repositorio:

Repositorio UdeA

Idioma:

eng

OAI Identifier:

oai:bibliotecadigital.udea.edu.co:10495/34378

Acceso en línea:

https://hdl.handle.net/10495/34378
https://doi.org/10.4269/ajtmh.2010.10-0060

Palabra clave:

Efficacy
Eficacia
Treatment Outcome
Resultado del Tratamiento
Leishmaniasis, Cutaneous
Leishmaniasis Cutánea

Rights

openAccess

License

http://creativecommons.org/licenses/by/2.5/co/